Concentrations of triglycerides are increased and concentrations of high-density lipoprotein (HDL) cholesterol are low in women with hyperandrogenism. These alterations could be related to excessive androgen or estrogen, to hyperinsulinism, or to a combination of these abnormalities. We examined their independent influences on lipids in 21 women with hyperandrogenism, subgrouped according to apparent source of androgen excess. Results for lipid, androgen, and insulin did not differ among subgroups, so these data were pooled. Free plus albumin-bound testosterone (uT) was correlated with triglycerides (r = 0.69, P <0.01) and HDL cholesterol (r -0.56, P < 0.01). Both triglycerides (r = 0.66, P <0.01) and HOL cholesterol (r = -0.48, P <0.05) were also correlated with insulin measured during fasting. Partial correlation revealed that, after adjusting for insulin, lipids were associated with uT. This suggests that androgen excess is independently related to lipid excess. Insulin also was correlated with lipids when adjusted for uT. Free plus albumin-bound estradiol was not associated with any of the lipids. We conclude that altered lipids in women with hyperandrogenism result from the independent effects of androgen and insulin. Insulin also plays a major role in the regulation of hepatic lipoprotein synthesis (5). In a wide range of patient groups, increased values for insulin measured during fast-
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do (4).
Insulin also plays a major role in the regulation of hepatic lipoprotein synthesis (5). In a wide range of patient groups, increased values for insulin measured during fast-as insulin, measured preprandially, have been found in association with lipoprotein abnormalities.
For example, previous studies demonstrated that many women with polycystic ovarian syndrome, the most common endrocrinopathy associated with hyperandrogenism, have increased triglyceride and decreased HDL-C concentrations (6) . Moreover, these associations were independent of alterations in body weight (7) . This syndrome is associated with insulin resistance and increased preprandial values for insulin concentration, both of which are independent of obesity.
Among the hypotheses to explain the lipid abnormalities in patients with this syndrome is that insulin resistance and excess circulating insulin could be a primary event causing both the lipid abnormalities and androgen excess, the latter mediated by an effect of insulin on the ovary (8) . Or the androgen excess itself could account for the lipid abnormalities and the insulin-resistant state could be unrelated. Or both androgens and increased insulin could contribute independently to the lipid excess. To distinguish among these hypotheses, we utilized statistical methods to determine the relative contributions of hyperinsulinism and hyperandrogenism in altering lipoprotein lipid patterns in a different population of women with hyperandrogenism than had been reported earlier. The data suggest that both androgens and insulin influence lipid metabolism independently.
Materials and Methods

Hormone and Protein Binding Assays
Blood was sampled between 0800 and 1000 hours from the antecubital vein of subjects who had fasted 12 h or more. None had consumed alcohol for at least 48 h before the sampling. The samples were coded, centrifuged, and stored frozen until assayed (-20 #{176}C).
Plasma glucose was determined by glucose oxidase methodology in a continuous-flow (SMAC) analyzer. Insulin concentrations (fasting and 2 h after a meal), sex-hormone binding globulin (SHBG), plasma testosterone (T), free plus albumin-bound testosterone (uT), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), estrone (E,), estradiol (E2), and free plus albumin-bound estradiol CuE) were measured according to previously reported methods (9-11). All of the women had documented hyperandrogenism, defined as increased free and albumin-bound testosterone or increased dehydroepiandrosterone sulfate, or both (Table 1). We considered it likely that these patients' androgen excess probably had a variety of etiologies. However, because categorization into subgroups was known to be arbitrary, we used the following strategy. Initially, patients were placed into arbitrary subgroups; when we found no statistically significant differences in lipid, insulin, or androgen measurements among these subgroups, we pooled the data on all the women.
Lipids and Lipoprotein Lipids
The patients in the overall group were initially categorized into those with polycystic ovarian syndrome, those with presumed idiopathic ovarian hyperandrogenism, and those with adrenal hyperandrogenism.
Eight women had polycystic ovarian syndrome, defined as lutropin/follitropin mass-concentration ratio >1.5 with or without increased DHEAS concentrations; their ovarian size varied between 3 and 5 cm, determined by pelvic examination.
Nine of the women were thought to have idiopathic ovarian hyperandrogenism;
i.e., there was no ovarian enlargement, DHEAS concentrations were within normal limits, and the lutropin/follitropin ratio was <1.5. Four women were presumed to have adrenal hypeiandrogenism, in that no ovarian enlargement was encountered, the lutropin/follitropin ratio was <1.5, and DHEAS concentrations were increased. When no differences in lipid, insulin, or androgen results were detected among subgroups, data from all women were pooled for analysis.
Corticotropin-stimulation studies to test for adult-onset congenital adrenal hyperplasia
were not performed because of the infrequency of its occurrence outside of high-#{149} Ferriman and Gallweyscore (14) . #{176} androgens, of the estrogens, and of the insulin and glucose results with the lipoprotein lipid measurements. Evidence for independent effects of insulin and androgens on lipid concentrations is gained by use of statistical adjustments for insulin and for uT effects. The partial correlation is determined as the correlation between the residual triglycerides (the part not explained by preprandial values for insulin) and the residual uT (the part not explained by preprandial values for insulin). Because smoking can affect lipoprotein lipid proffles, we repeated the analyses with the data from the three potential smokers deleted, with essentially the same results. All computations were made by using SAS Institute (Cary, NC) procedures, 1985 edition.
Results
Clinical and Hormonal Results
The patients ranged in age from 23 to 34 years (Table 1) . Nineteen were hirsute; none was virilized. Seven patients had a strong family history of heart disease, defined as an immediate family member with coronary artery disease before age 50. Most of these family histories involved a male family member. None of the patients was hypertensive, defined as diastolic blood pressure >90 mml-Ig; the patient with the highest blood pressure had a value of 142/78, and she was 141% of ideal body weight. Only one patient reported using alcohol on a weekly basis or more frequently.
Patient subgroups defined by regularity of menses and by family history of heart disease did not differ significantly with respect to lipoprotein lipid, androgen and glucose, or insulin profiles. The obese women had higher preprandial and 2-h postprandial insulin concentrations and greater systolic blood pressures than did the non-obese women. Free plus albuminbound testosterone was associated positively with triglyceride concentrations (r = 0.69) and negatively with HDL-C (r = -0.56) (both P <0.01). Neither free plus albuminbound estradiol (uE) nor the ratio of uE to uT (uE/uT) were associated with any of the lipids or the lipoproteins. Because insulin is known to influence lipid metabolism, the second hypothesis-that insulin is related to the lipoprotein lipid alterations-was next examined. Correlation of insulin results with values for lipoprotein lipid indicated that both preprandial insulin and 2-h insulin were significantly associated with triglyceride concentrations (r = 0.66 and 0.48, respectively) and that preprandial insulin (but not 2-h insulin) was negatively associated with HDL-C (r = -0.48). No correlation of free and albumin-bound estrathol with any lipid variable was detected. After univariate correlations were found with lipoprotein lipids for both uT and insulin, we examined potential confounding associations (Table 4) , finding a positive correlation of uT with fasting and 2-h insulin. This suggested that the correlations of both insulin and androgens with lipids might be interdependent.
We also found correlations of body weight with SHBG, which could confound interpretations of the uT values. These associations necessitated use of statistical methods to minimize the influence of these confounding factors.
Partial Correlation Analysis
To examine whether values for insulin and androgen might be independently related with lipid concentrations, #{149} Low-density-lipoproteincholesterol (other abbreviations in footnote6).
we used partial correlation analysis with adjustment for confounding factors. When adjusting for prepranthal insulin the association of triglycerides and uT (r = 0.56, P <0.01, Figure 1 ) remained significant. Partial correlation also revealed that the association between HDL-C and uT remained relatively strong when adjusted for fasting insulin (r = 0.42, P <0.06). The association between triglycerides and fasting insulin concentrations was significant (r = 0.50, P <0.02) after it was adjusted for uT, but the association of HDL-C with fasting insulin then became non-significant.
Thus, both uT and insulin are independently associated with triglycerides, but uT has more independent influence on HDL-C than does insulin.
Bioassay of Androgen/Estrogen Balance
Measurement of SHBG is a bioassay that is considered to reflect androgenlestrogen balance. Androgens lower SHBG concentrations; estrogens increase their concentrations. Obesity also lowers SHBG concentrations, but this factor can be adjusted for by statistical methods. Excess androgen concentrations without excess estrogen concentrations should lower SHBG and be correlated with an increase in triglycerides and a decrease in HDL-C. To confirm this, we examined the association of SHBG with the individual lipoprotein lipids ( Table 3) . A significant negative correlation of SHBG with triglycerides and a positive correlation with HDL-C independent of percent ideal body weight was found (r = -0.75, P <0.01 and r = 0.62, P <0.01, respectively). The correlations, after adjusting for percent ideal body weight and fasting insulin, were r = 0.55, P <0.05 and r = 0.45, P <0.06, respectively. These findings are compatible with the concept that SHBG concentrations reflect systemic androgen effects. In contrast to the androgens and SHBG, no significant correlations were found between uE or the uE/uT ratio and any of the lipoprotein lipids.
Clinical states of androgen excess in women are known to be associated with increased triglyceride and decreased HDL-C concentrations. The precise mechanisms for these concentrations when statistical methods were used to identifr independent effects. In addition, androgen, when corrected for insulin, also was found to be correlated with lipid concentrations.
Thus, both insulin and androgen appear to act independently to alter lipid metabolism. These data are also compatible with the possibility that insulin concentrations influence those of both SHBG and lipid, because the above correlations were weaker after adjusting for insulin. Certain in vitro data suggest that insulin can independently affect SHBG (18), as do certain epidemiological data (19) .
Over the past two decades, a variety of clinical studies have supported the concept that increased values for proprandially measured insulin, as a result of insulin resistance, may be causally related to increased triglyceride production in certain patients. This pathogenic mechanism has been invoked to explain the lipid abnormalities in women with polycystic ovarian syndrome and insulin resistance. However, increased androgens, which can also markedly influence lipid metabolism, are present in polycystic ovarian syndrome patients.
Investigators recently have postulated that insulin and androgen concentrations are causally interrelated.
Insulin itself or insulin-like activity (i.e., insulin-like growth factors) stimulate ovarian androgen production in vitro. The key abnormality may then be insulin resistance, which causes insulin excess, and, secondarily, the insulin causes increased androgen production.
The correlation between prepranthal insulin and free and albumin-bound testosterone concentration in the present study is consistent with this hypothesis, as are the correlations between the lipid abnormalities and fasting insulin and free and albumin-bound testosterone. However, a direct and independent effect of androgens on lipid metabolism in our patients also appears probable. Androgens are known to exert major effects on lipid metabolism in pa- tients without known insulin resistance. In our patients, the association between uT and triglyceride concentrations remained highly significant when corrected for preprandial concentrations of insulin. These results strongly suggest that both increased insulin and uT independently contribute to the lipid abnormalities. This conclusion, however, is based upon results from statistical correlations, which provide only indirect evidence of independence. Interventional studies to lower androgens with gonadotropin-releasing-hormone analogs without altering values for insulin are now needed to confirm these conclusions more directly.
The degree of the lipoprotein lipid alteration detected was variable-not surprising, because women with androgen excess represent a heterogeneous group of disorders with varying degrees of hyperandrogenism.
The clinical entity referred to as polycystic ovary syndrome has remained controversial since Stein and Leventhal (20) first described it in 1935. Close examination reveals that, in virtually all studies of this syndrome, a heterogeneous group defined by non-uniform criteria was being evaluated (21-24) . Similarly, the women in the present study are a heterogeneous group with hyperandrogenism as indicated by the subgroups of ovarian and adrenal androgen excess. We did not try to evaluate the effect of all possible disorders, such as adult-onset congenital adrenal hyperplasia. However, subgroups of women with this syndrome and with presumed ovarian and presumed adrenal androgen excess were studied. All women were evaluated for their clinical concerns of manifestations of androgen excess. The common thread was demonstrable hyperandrogenism. Similarly, we found no evidence for a heterogeneous lipoprotein lipidlinsulin response in these disorders independent of the degree of hyperandrogemsm.
Interestingly, seven of the women had a strong family history of coronary artery disease and, when it was present, the usual male preponderance was found. The lipid alterations were not different in these seven subjects. Possibly the hyperandrogemc pattern observed in the group here supersedes that of familial hypercholesterolemia.
The lipoprotein lipid alterations are similar to previous findings (6, 7) in another population of hirsute women. Investigations of lipoprotein lipid concentrations in women with polycystic ovarian syndrome are infrequent.
Wortsman and Sober (25) found decreased HDL-C concentrations in these women (but no control patients were evaluated). Mattson et al. (26) found increased triglycerides and verylow-density cholesterol but no difference in HDL-C in hirsute women with oligoamenorrhea.
Nor could they find correlations between sex steroids and lipoprotein alterations. This may be explained by different methodologies used to measure lipoprotein lipids or sex steroids, or both; by different patient populations studied; or by other factors. All authors, however, find altered lipoprotein lipid profiles that suggest that these women are potentially at greater risk for coronary artery disease.
These results have implications for sex differences in the incidence of coronary artery disease. Women with androgen excess represent a biological "experiment in nature" to illustrate the effect of sex steroids on lipoprotein lipids. Disorders of androgen excess are more common than is generally realized. Some estimate that 15% of women are affected. Abnormal lipoprotein lipid profiles and insulin excess appear to be independent risk factors for coronary artery disease (27) (28) (29) (30) . Men die in greater numbers and at earlier age from ischemic heart disease than do women (31). Women with normal estrogen/androgen proffles have less insulin resistance and favorable (i.e., "female") lipid profiles. On the other hand, women with insulin resistance as a result of obesity and (or) abnormal androgen/estrogen proffles (adipose distribution also may be involved) lose their favored cardiovascular low-risk status (29), especially if diabetes supervenes (32) (33) (34) (35) (36) (37) . Thus, it may be that insulin sensitivity per se, mediated by adiposity, distribution, and estrogen/androgen status (especially androgens), determines cardiovascular risk status. These results in androgenized women are supported by recent epidemiological data on men showing that testosterone and insulin are linked to ischemic heart disease (38) . The hypothesis that differences in endogenous sex steroids and insulin resistance might explain sex-related differences in coronary artery disease needs to be evaluated in greater detail.
Lipoprotein lipid proffles in individual patients are determined by multiple factors, including genetic, dietary, exercise, drug use, and smoking habits (39). The magnitude of risk for coronary artery disease in women with hyperandrogenism is hard to quantify without data on incidence at various ages. Nonetheless, many of these women are heavier, are more sedentary, have higher blood pressure (26), and may consume diets higher in saturated fats and low in fiber (6) , so counseling to reduce risk factors is indicated.
Evaluation of the metabolic consequences of treatment modalities to control manifestations of androgen excess is warranted.
